You have 9 free searches left this month | for more free features.

gene

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Glucose Metabolism Disorders Trial in Aarhus (Melatonin, Placebo)

Completed
  • Glucose Metabolism Disorders
  • Aarhus, Denmark
    Aarhus University Hospital
Mar 24, 2020

Overweight Trial in Oslo (Low met/cys diet, Moderate met/cys diet, High met/cys diet)

Completed
  • Overweight
  • Low met/cys diet
  • +2 more
  • Oslo, Norway
    University of Oslo
Mar 23, 2020

Pulmonary Hypertension, Hypoxia and Sickle Cell Disease

Completed
  • Chuvash Polycythemia
  • +3 more
    • Washington, District of Columbia
    • +6 more
    Dec 13, 2019

    Advanced Cancer Trial in Korea, Republic of, United States (MGCD516)

    Unknown status
    • Advanced Cancer
    • Birmingham, Alabama
    • +42 more
    Jan 28, 2020

    Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v7, Stage III Rectal Cancer AJCC v7 Trial in Puerto Rico, United States

    Active, not recruiting
    • Rectal Adenocarcinoma
    • +2 more
    • Birmingham, Alabama
    • +649 more
    Aug 5, 2022

    COVID-19 Trial in Xi'an (Alpha-interferon alpha, abidol, ribavirin, Buzhong Yiqi plus and minus formula, Huhuang Detoxicity

    Active, not recruiting
    • COVID-19
    • Alpha-interferon alpha, abidol, ribavirin, Buzhong Yiqi plus and minus formula, Huhuang Detoxicity Paste, Baimu Qingre Jiedu Paste, fumigation/inhalation of vitamin C
    • +2 more
    • Xi'an, Shaanxi, China
      Xi'an International Medical Center Hospital
    Dec 9, 2020

    Genetic Variants Associated With Pentalogy of Cantrell

    Completed
    • Pentalogy of Cantrell
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Mar 8, 2019

      Malignant Tumor of Breast Trial in Iran, Islamic Republic of (Trastuzumab plus docetaxel (for four 21-day cycles) after four

      Completed
      • Malignant Neoplasm of Breast
      • Trastuzumab plus docetaxel (for four 21-day cycles) after four 14-day cycles of Doxorubicin plus cyclophosphamide
      • Ahvaz, Iran, Islamic Republic of
      • +18 more
      Jul 8, 2020

      Development of Celiac Disease in Genetically Predisposed

      Enrolling by invitation
      • Prevention of Clinical Symptoms in Celiac Disease
      • analysis of genetic and epigenetic risk factors
      • Naples, Campania, Italy
        University of Naples Azienda Ospedaliera Universitaria
      Jul 31, 2019

      Radiation Toxicity, Advanced Cancer, Radiosensitivity Trial in Jinan (next generation sequence)

      Unknown status
      • Radiation Toxicity
      • +2 more
      • next generation sequence
      • Jinan, Shandong, China
        Shandong Cancer Hospital and Institute
      Sep 29, 2019

      Peri-Implantitis, Periodontal Diseases Trial in Catania (Harvested)

      Completed
      • Peri-Implantitis
      • Periodontal Diseases
      • Harvested
      • Catania, Italy
        University School of Dental Medicine
      Jan 6, 2020

      Longterm Follow-up of Subjects Treated With bb2121

      Completed
      • Multiple Myeloma
      • Safety and efficacy assessments
      • Palo Alto, California
      • +8 more
      Jan 20, 2020

      Pulmonary Disease, Chronic Obstructive, Microbiota Trial in Seoul (Obtain samples from sputum and feces)

      Not yet recruiting
      • Pulmonary Disease, Chronic Obstructive
      • Microbiota
      • Obtain samples from sputum and feces
      • Seoul, Korea, Republic of
        Department of Pulmonary and Critical Care Medicine and Clinical
      Apr 3, 2020

      Prostatic Tumors, Immunotherapy, Dendritic Cells Trial in Nijmegen (mDC vaccination, pDC vaccination, mDC and pDC vaccination)

      Completed
      • Prostatic Neoplasms
      • +3 more
      • mDC vaccination
      • +2 more
      • Nijmegen, Gelderland, Netherlands
        Radboud University Nijmegen Medical Centre
      Nov 13, 2019

      Drug Resistant Epilepsy: Clinical and Genetic Study

      Unknown status
      • Epilepsy, Drug Resistant
      • Genetic study for SCN1A c.3184 A/G and CCL2-2518G>A polymorphism:
      • Mansoura, Egypt
        Mansoura University Hospital
      Nov 14, 2019

      Colorectal Cancer Trial in Durham (Panitumumab, Cabozantinib)

      Completed
      • Colorectal Cancer
      • Durham, North Carolina
        Duke Cancer Center, Duke University Medical Center
      Feb 9, 2021

      Breast Cancer in Poland: An Expanded Study to Assess

      Completed
      • Ovarian Neoplasms
      • +4 more
        • Lodz, Poland
        • +1 more
        Apr 16, 2020

        Androgenetic Alopecia: A Systematic Review and Meta-analysis

        Unknown status
        • Androgenetic Alopecia
          • Assiut, Assiut Governorate, Egypt
            Assiut University
          Jan 6, 2020

          Tissue Acquisition Study of Adrenocortical Carcinoma

          Completed
          • Adrenocortical Carcinoma
            • Bethesda, Maryland
              National Institutes of Health Clinical Center, 9000 Rockville Pi
            Dec 11, 2019

            Serum LncRNAs as Early Potential Biomarkers for Prediction of

            Unknown status
            • Preeclampsia
              • Harbin, Heilongjiang, China
                Serum LncRNAs as Potential Biomarkers for the Prediction of Pree
              Dec 16, 2019

              Migraine Trial in Japan (Galcanezumab, Placebo)

              Completed
              • Migraine
              • Chiba, Japan
              • +46 more
              Apr 1, 2021

              Age Gene/Environment Susceptibility Reykjavik Study

              Completed
              • Neoplasms
                • (no location specified)
                Aug 30, 2017

                CYP2D6 Polymorphism in Patients of General Practice in Austria

                Completed
                • Disorder Due Cytochrome P450 CYP2D6 Variant
                  • Angern, Lower Austria, Austria
                    Practice Office
                  Oct 7, 2019

                  Breast Cancer in Women of Different Races

                  Withdrawn
                  • Breast Cancer
                  • Mastectomy
                  • Baltimore, Maryland
                    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
                  Feb 21, 2019

                  BRAF Gene Mutation, Hepatic Complication, Renal Failure Trial in Canada, United States (Dabrafenib, Laboratory Biomarker

                  Terminated
                  • BRAF Gene Mutation
                  • +3 more
                  • Duarte, California
                  • +17 more
                  Aug 13, 2018